FDA not heeding advisory committees
Executive Summary
Advisory committee recommendations are not followed by FDA as often as generally thought, Public Citizen asserts in a recent letter in The Lancet. The public interest group claims the agency's regulatory actions were inconsistent with committee recommendations 28 percent of the time based on an analysis of FDA advisory committees from Jan. 1, 1997 through June 30, 2006. The study also finds the frequency of committee meetings prior to approval of new molecular entities declined from 40 and 52 percent in 1998 and 1999 to 24 percent for the 2000-2006 period. FDA's advisory committee process has come under heavy criticism in the past year, with editorials by advisory committee members, a Public Citizen study on conflicts of interest, and a negative report from the National Research Center for Women and Families (1"The Pink Sheet" Sept. 11, 2006, p. 22)...
You may also be interested in...
FDA Considering New Metrics To Evaluate Advisory Panel Member Conflicts
In response to concerns about conflicts of interests involving advisory committee members, FDA has started to examine possible metrics to assess panelists' expertise and relationships with regulated companies
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.